Winship | Strategic Alliance Partners

Latest from Winship


Saba Speaks to Tipifarnib and Targeting HRAS in Head and Neck Cancer

November 12, 2020

In our exclusive interview, Nabil F. Saba, MD, FACP, sheds light on the implications of targeting HRAS in head and neck squamous cell carcinoma, details the data that has been reported to date with tipifarnib, and shares his expectations for the ongoing KO-TIP-007 trial.

x